BenevolentAI is growing to scale our work with biopharma companies globally, helping them solve their most complex drug discovery problems with our leading suite of AI solutions. To support this BenevolentAI is seeking a motivated Revenue Strategy Associate to join the revenue function and support the development and execution of our go to market strategy.
Responsibilities
- You will work closely with revenue leadership and across the commercial functions to support development of revenue strategy and effective execution
- You will be responsible for competitive intelligence, identifying both challenges and opportunities and making recommendations to key stakeholders on how the business can improve and grow
- You will be involved in aspects of commercial due diligence, carrying out qualitative and/or quantitative research to support the assessment of BenevolentAI’s commercial offerings
- You will be responsible for carrying out market research and communicating market trends to key stakeholders in the business
- You will be responsible for profiling potential customer segments and customers, as well as partners
- Support to identify and establish strategic partnership opportunities (eg joint ventures, strategic alliances and any other potential collaborations)
- Collaborate with internal product, sales and marketing, customer success, and scientific teams to support the development of revenue strategy and product strategy (e.g. pricing, commercial models etc.)
We are looking for:
- 2-4 years of relevant experience working in growth technology, biopharma, or professional services companies serving these sectors
- Experience in market analysis and commercial due diligence
- Experience in the pharmaceutical or biotech industry, ideally with a drug-discovery focus
- Can-do attitude and proactive and collaborative approach to problem solving
- Eagerness to learn about AI applied to Life Sciences
- Excellent communication skills
- Optional, but a net plus:
- Experience in tech applied to the life sciences and/or the pharmaceutical industry
- Experience in evaluating investment opportunities
- Experience in asset licensing
BenevolentAI (AMS: BAI) is a leading developer of advanced artificial intelligence technologies that unlock the value of multimodal data, surface novel insights, and accelerate biomedical discovery. Through the combined capabilities of its AI platform, its scientific expertise, and wet-lab facilities, the Company is developing an in-house drug pipeline of high-value assets. The Company is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.